XCELL THERAPEUTICS INC. financial statements, including revenue, expenses, profit, and loss

The total revenue of 373110 for the last quarter is 478.29 M KRW, and it's 8.33% lower compared to the previous quarter. The net income of Q2 24 is -2.14 B KRW.